KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Hims & Hers Health (HIMS) Research & Development (2021 - 2025)

Hims & Hers Health's Research & Development history spans 5 years, with the latest figure at $41.0 million for Q4 2025.

  • For Q4 2025, Research & Development rose 72.48% year-over-year to $41.0 million; the TTM value through Dec 2025 reached $149.3 million, up 89.42%, while the annual FY2025 figure was $149.3 million, 89.42% up from the prior year.
  • Research & Development for Q4 2025 was $41.0 million at Hims & Hers Health, up from $40.6 million in the prior quarter.
  • Across five years, Research & Development topped out at $41.0 million in Q4 2025 and bottomed at $6.1 million in Q1 2022.
  • The 5-year median for Research & Development is $13.4 million (2023), against an average of $18.3 million.
  • The largest annual shift saw Research & Development increased 27.8% in 2022 before it skyrocketed 102.89% in 2025.
  • A 5-year view of Research & Development shows it stood at $6.2 million in 2021, then surged by 33.15% to $8.3 million in 2022, then surged by 61.29% to $13.4 million in 2023, then soared by 77.17% to $23.7 million in 2024, then soared by 72.48% to $41.0 million in 2025.
  • Per Business Quant, the three most recent readings for HIMS's Research & Development are $41.0 million (Q4 2025), $40.6 million (Q3 2025), and $37.8 million (Q2 2025).